Trials / Completed
CompletedNCT01915446
Kidney and Intestinal Markers for Early Detection of Organ Injury After Endovascular Aortic Repair
Kidney and Intestinal Markers for Early Detection of Organ Injury After Endovascular Aortic Repair - The KISMED Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- University Hospital Regensburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the predictive value of novel biomarkers and contrast-enhanced ultrasonography for early detection of abdominal end-organ (kidney and intestinum) hypoperfusion and ischemia in patients undergoing endovascular aortic repair (EVAR) for aortic aneurysm or dissection. In this context, patients will be monitored for renal biomarkers (TIMP-2, IGFBP7) and intestinal biomarkers (plasmatic intestinal fatty acid binding protein (i-FABP)) and local tissue perfusion will be assessed using contrast-enhanced ultrasonography (CEUS). The ultimate goal of this study is an early identification of patients developing one or both of these complications, which may facilitate a timely intervention to improve outcome.
Conditions
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2013-08-05
- Last updated
- 2014-12-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01915446. Inclusion in this directory is not an endorsement.